675.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$678.39
Aprire:
$677.53
Volume 24 ore:
2.09M
Relative Volume:
1.02
Capitalizzazione di mercato:
$249.58B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
37.11
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
+3.62%
1M Prestazione:
+7.46%
6M Prestazione:
+37.54%
1 anno Prestazione:
+46.99%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
675.00 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
224.49 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
412.56 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
172.79 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
|
IQV
Iqvia Holdings Inc
|
270.37 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-09 | Aggiornamento | UBS | Neutral → Buy |
| 2026-09-03 | Iniziato | CLSA | Outperform |
| 2026-06-26 | Ripresa | Bernstein | Mkt Perform |
| 2026-06-11 | Iniziato | Piper Sandler | Neutral |
| 2026-06-03 | Downgrade | HSBC Securities | Buy → Hold |
| 2026-06-02 | Ripresa | Wolfe Research | Outperform |
| 2026-05-15 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher stock last at USD 670.38, down 1.18 percent in New York trading - AD HOC NEWS
Thermo Fisher Scientific's Building Blocks to 2028 Growth 'Fundamentally Sound,' Deutsche Bank Says - Yahoo Finance
Thermo Fisher Scientific Inc (CEUX:TN8d) Stock PDF (Updated: 2026/09/25) - gurufocus.com
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Thermo Fisher Scientific stock gains 1.97 percent near yearly high - AD HOC NEWS
What Is Changing for Thermo Fisher Scientific (NYSE:TMO)? - Kalkine Media
Thermo Fisher Scientific stock rises 1.64 percent ahead of the open - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Stock Hits Record High: What's Happening? - Benzinga
Dodge and Cox’s Bullish Stance on Thermo Fisher Scientific (TMO) - Yahoo Finance
Thermo Fisher Scientific stock hits 52-week high at 671.69 USD - Investing.com Canada
Thermo Fisher Scientific stock gains 1.03 percent on results - AD HOC NEWS
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher - Yahoo Finance
Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher - Investing.com
Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question - Yahoo Finance
Biodesix Announces Progress on Tumor-Informed and Tumor-Naïve MRD Programs with Bio-Rad and Thermo Fisher - Quiver Quantitative
Global Automated and Closed Cell Therapy Processing Systems Market Set for Expansion as Scalable Workflows Drive Growth, 2026-2033 - GlobeNewswire Inc.
Thermo Fisher Scientific (TMO) Rolls Out New Media Panel For Biologics Development - Yahoo Finance
Thermo Fisher Scientific stock gains before the bell - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific stock gains at the close - AD HOC NEWS
Thermo Fisher, Bird, BRS at 52-Week Highs on News - baystreet.ca
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development - BioSpace
Thermo Fisher launches CHO-K1 cell culture media panel By Investing.com - Investing.com Canada
Thermo Fisher Scientific stock holds near its yearly high - AD HOC NEWS
Thermo Fisher Scientific stock slips 0.20 percent ahead of the open - AD HOC NEWS
Thermo Fisher stock rises 0.30 percent at the close - AD HOC NEWS
Transport Media Market Is Going to Boom with Thermo Fisher - openPR.com
Top 3 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
Thermo Fisher Scientific stock rises 1.23 percent near its yearly high - AD HOC NEWS
Thermo Fisher Scientific stock heads into the open after a 0.51 percent gain - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Monday, still underperforms market - MarketWatch
Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today - Benzinga
Mayo Clinic, Thermo Fisher partner to create biomedical database - Healthcare Dive
Mayo Clinic, Thermo Fisher partner to create Precure - MedTech Dive
Thermo Fisher Scientific stock gains as investors eye upcoming earnings and dividend - AD HOC NEWS
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $780 From $650, Maintains Buy Rating - marketscreener.com
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Market with Strong Buy Ratings and Robust Revenue Growth - DirectorsTalk Interviews
Thermo Fisher stock ends the day higher at the close on the NYSE - AD HOC NEWS
Thermo Fisher Scientific stock eases after guidance raise and solid second-quarter growth - AD HOC NEWS
Thermo Fisher Scientific to Present at the Morgan Stanley 24th An - The National Law Review
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific (TMO) is Positioned for Resurgence - Yahoo Finance
What Makes Thermo Fisher Scientific (NYSE) Worth Watching Now? - kalkinemedia.com
Three Analysts, Three Verdicts on Thermo Fisher: Here’s Who the Numbers Favor - Yahoo Finance
Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform? - Yahoo Finance
Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’ - Yahoo Finance
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst - finance.yahoo.com
A Look at Thermo Fisher Scientific Inc (TMO) After 4.5% Gain -- GF Value $598.67 vs Price $641.39 - GuruFocus
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.44% on Sep 15: Facts Behind the Movement - TradingKey
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):